Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Velocity Clinical Research- East Greenwich, Rhode Island

Verified

Basic Information

Site Overview

Source: Human-provided.

Velocity's research site in Providence was founded in 1993 as Omega Medical Research by Johnna Pezzullo, BSN, RN and Lynne Haughey, MSN, FNP, and acquired by Velocity in 2020. The founders’ guiding principles were to be a site that: takes pride in its work and quality; is concerned with subject safety first and foremost; and where continuous quality improvement is a priority. Considered to be Rhode Island’s premier research center, our Providence site is centrally located in the state, and is easily accessible to both study participants and sponsors. As a multi-specialty research facility, this site has conducted over 400 Phase 1-4 clinical drug and device trials. Our Providence staff has extensive multi-therapeutic experience, including in Cardiovascular, Gastroenterology, Dermatology, Rheumatology, Women’s Health, and Vaccine studies.Located just off I-95 in a large medical building with on-site parking, the site is easily accessible. With more than 9200 square feet of research…

Business Status

Source: Human-provided. OPEN

Business Category

Source: Human-provided. Medical group

Business Subcategory

Source: Human-provided. Medical group
Source: Trial-derived.
30Total Trials
Source: Trial-derived.
1Recruiting Trials
Source: Trial-derived.
7Active Trials
Source: Trial-derived.
22Completed Trials
Source: Trial-derived.
32Unique Conditions
Source: Trial-derived.
18Unique Sponsors

Affiliations

Conditions

Source: Trial-derived. COVID-19 (3)Source: Trial-derived. Obesity (3)Source: Trial-derived. SARS-CoV-2 (3)Source: Trial-derived. Type 2 Diabetes (2)Source: Trial-derived. Adult Obesity (1)Source: Trial-derived. Celiac Disease (1)Source: Trial-derived. Coeliac Disease (1)Source: Trial-derived. Dermatitis Atopic (1)

Sponsors

Source: Trial-derived. ModernaTX, Inc. (4)Source: Trial-derived. Novo Nordisk A/S (4)Source: Trial-derived. Merck Sharp & Dohme LLC (3)Source: Trial-derived. Sanofi (3)Source: Trial-derived. Sanofi Pasteur, a Sanofi Company (3)Source: Trial-derived. Regor Pharmaceuticals Inc. (2)Source: Trial-derived. AbbVie (1)Source: Trial-derived. Biomedical Advanced Research and Development Authority (1)

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Electronic data capture
Source: AI-inferred. Telehealth study visits

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Continuous glucose monitoring

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Clinical microbiology culture
Source: AI-inferred. PCR / molecular

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Blood glucose meter monitoring
Source: AI-inferred. Cardiac monitoring
Source: AI-inferred. Hemagglutination inhibition (HI) serology assay
Source: AI-inferred. Ophthalmic examination
Source: AI-inferred. Ophthalmologic examination
Source: AI-inferred. Ophthalmological retinopathy examination